CHMP rec­om­mends eight new drug ap­provals, six la­bel ex­pan­sions

It was a pos­i­tive week for the Eu­ro­pean Med­i­cines Agency’s hu­man med­i­cines com­mit­tee (CHMP), which rec­om­mend­ed the ap­proval of eight new drugs in­clud­ing Take­da’s Fruza­qla …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER